Improvement of EPO-resistance in Hemodialysis Patients With Chronic Inflammation by High Cut-off Hemodialysis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
Chronic inflammation in dialysis patients is linked to cardiovascular mortality and clinical signs and symptoms, like the impaired response to erythropoiesis-stimulating agents (ESAs). This study aims to demonstrate that high cut-off hemodialysis is effective in reducing chronic inflammation and thereby improving response to ESAs.
Epistemonikos ID: e894ceaca80ff9d0f46353666cee7f45d1030f18
First added on: May 10, 2024